Harte-Hanks, Inc. (HHS) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.20 -1.64%
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Harte-Hanks, Inc. (NYSE: HHS) reported Q3 EPS of $0.19, $0.01 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $212.79 million versus the consensus estimate of $213.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
